What is the recommended dosing strategy when switching from Xanax (alprazolam) 1mg twice daily (BID) to Klonopin (clonazepam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Alprazolam 1mg BID to Clonazepam

Direct substitution using a 0.5mg clonazepam equivalent for each 1mg alprazolam dose is the recommended approach, starting with clonazepam 0.5mg BID and titrating as needed. 1, 2

Conversion Strategy

The standard conversion ratio is 1mg alprazolam = 0.5mg clonazepam, making the equivalent starting dose clonazepam 0.5mg BID (total 1mg daily) for a patient taking alprazolam 1mg BID. 2

Direct Substitution Method

  • Abruptly switch from alprazolam to clonazepam using the equivalent dose without tapering the alprazolam first. 2
  • This approach has been demonstrated safe and effective in 37 alprazolam-dependent patients, with no withdrawal seizures observed and only 2 patients experiencing rebound panic symptoms. 2
  • The longer elimination half-life of clonazepam (20-80 hours) compared to alprazolam (12 hours) provides more continuous anxiolytic coverage and minimizes rebound anxiety between doses. 3

Dosing Schedule

  • Start clonazepam 0.5mg twice daily (morning and evening) when discontinuing alprazolam 1mg BID. 1, 2
  • For panic disorder specifically, the FDA-approved initial dose is 0.25mg BID, but given the patient is already on equivalent benzodiazepine therapy, starting at 0.5mg BID is appropriate. 1
  • Maximum dose is 4mg daily if needed for symptom control, though 1mg daily is typically the optimal dose for panic disorder. 1

Clinical Advantages of This Switch

Clonazepam offers several benefits over alprazolam that justify this transition:

  • Less frequent dosing required due to the 20-80 hour half-life versus alprazolam's 12-hour half-life, allowing BID dosing to provide 24-hour coverage. 3, 4
  • Reduced interdose rebound anxiety because plasma levels decline more gradually. 3, 4
  • Easier eventual discontinuation if needed, as the longer half-life produces less severe withdrawal symptoms. 3, 4
  • Comparable efficacy to alprazolam for panic disorder and anxiety, with similar onset of action. 5, 4

Monitoring and Titration

  • Assess response after 3 days and consider increasing by 0.25mg increments every 3 days if symptoms are not adequately controlled. 1
  • The target maintenance dose for most patients with panic disorder is 1mg daily, though some may require up to 4mg daily. 1
  • Monitor for excessive sedation, which occurs in approximately 20% of patients on clonazepam and may necessitate dose reduction. 5

Critical Safety Considerations

Common side effects to anticipate during the transition include drowsiness, coordination difficulties, and potential cognitive effects. 1, 5

  • Administer one dose at bedtime if daytime somnolence becomes problematic, rather than splitting doses evenly. 1
  • Elderly patients may require lower starting doses and closer monitoring. 1
  • Avoid abrupt discontinuation of clonazepam if treatment needs to be stopped in the future; taper by 0.25mg per week. 6

Common Pitfalls to Avoid

  • Do not use a 1:1 conversion ratio (1mg alprazolam = 1mg clonazepam), as this would result in overdosing; the correct ratio is 1mg alprazolam = 0.5mg clonazepam. 2
  • Do not attempt a gradual cross-taper by slowly reducing alprazolam while introducing clonazepam, as direct substitution is safer and more effective. 2
  • Do not underdose initially out of excessive caution, as inadequate dosing may precipitate withdrawal symptoms or rebound anxiety. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.